Back to search
FDAFDA · Food and drugs·Recall number D-0645-2022

RISE UP RED EDITION Capsules, 650 mg, 10-count blisters packaged in a carton, ASIN B08JCWG84D, barcode X002NI8PE1.

Published March 2, 2022 · Recall initiated: February 10, 2022

Summary

FDA records drug Class I recall D-0645-2022, published March 2, 2022 and initiated February 10, 2022. Recalling firm: Positive Health; Status: Terminated; Reported quantity: 5,500 cartons; Lot: Lot # 48658908, Exp. date 09/09/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Positive Health
Distributor
Product was distributed nationwide via the internet through Amazon Marketplace.
Lot
Lot # 48658908, Exp. date 09/09/2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was RISE UP RED EDITION Capsules, 650 mg, 10-count blisters packaged in a carton, ASIN B08JCWG84D, barcode X002NI8PE1. recalled?

Yes. FDA published recall D-0645-2022 on March 2, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release